Acute Respiratory Distress Syndrome (ARDS) Market Size, Share, Growth Analysis 2033

1
Acute Respiratory Distress Syndrome (ARDS) Global
Market Report 2024
Global Forecast 2024 2033 Market Size, Drivers,
And Trends
Top Market Research Firm 2023! We are honored
to be listed as a top company at the forefront of
research, by the Business Management Review
2
Acute Respiratory Distress Syndrome (ARDS) Market
Segments
The Business Research Company segments the acute
respiratory distress syndrome (ards) market
report as
Diagnosis, Treatment
By Type
COVID-19 Disease 2019 (COVID-19), Sepsis,
Inhalation Of Harmful Substances, Severe
Pneumonia, Other Causes
By Cause
Mild, Moderate, Severe
By Severity
By End User
Hospitals, Clinics, Ambulatory Service Centers,
Other End Users
3
Market Statistics
The global Acute Respiratory Distress Syndrome
(ARDS) market size grew from 1.17 billion in
2023 to 1.29 billion in 2024 at a compound
annual growth rate (CAGR) of 10.6.  The Acute
Respiratory Distress Syndrome (ARDS) market size
is expected to grow to1.93 billion in 2028 at a
compound annual growth rate (CAGR) of 10.7
1.93 B
1.29 B
1.17 B
Click Here To Get A Sample Report
4
Key Market Drivers And Trends
Drivers
The growing prevalence of pneumonia is expected
to propel the growth of the acute respiratory
distress syndrome (ARDS) market going forward.
Trends
Major companies operating in the acute
respiratory distress syndrome (ARDS) market are
focusing on developing innovative drugs and
supplements, such as Aviptadil, HSP90 inhibitors
and others to sustain their position in the
market.
Region
North America was the largest region in the Acute
Respiratory Distress Syndrome (ARDS) market in
2023. The regions covered in the Acute
Respiratory Distress Syndrome (ARDS) market
analysis report are Asia-Pacific, Western Europe,
Eastern Europe, North America, South America,
Middle East and Africa.
5
Top Eleven Players In The Market

• Major players in the market are
• Johnson Johnson Services Inc.
• Novartis AG
• GlaxoSmithKline PLC
• Medtronic PLC
• Boehringer Ingelheim International GmbH
• Gilead Sciences Inc.

• Amgen Inc.
• Fresenius SE Co. KGaA
• Koninklijke Philips N.V.
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.

6
7 Reasons Why TBRC Is The Solution You Need

1. Global Macroeconomic Impact Assess global
   economic factors' influence on market growth.
2. Market Size Ratios Explore market size, GDP
   proportions, and expenditure per capita.
3. Global Perspective Reports cover 60 geographies
   for a comprehensive global understanding.
4. Localized Strategies Create region-specific
   strategies aligning with market nuances.
5. Investment Insights Identify growth segments
   through forecast data and market insights.
6. Competitor Benchmarking Compare performance
   against key competitors.
7. Presentation Support Reports offer reliable data
   for internal and external presentations.

7
Americas The Business Research Company, 1295 N
Providence Rd, Media, PA 19063, USA ? 1
3156230293
Get In Touch
Europe The Business Research Company 47 Anchorage
Point, 42 Cuba Street, Canary Wharf, London,
England, E14 8NE ? 44 207 1930 708
How ever you want to grow and expand, The
Business Research Company can help as we provide
research consulting solutions for businesses,
government agencies consultancies, and market
research companies.
Asia The Business Research Company, 1st Floor,
Anshu Colors Building, Road Number 1, Park View
Enclave, Jubilee Hills, Hyderabad (India),
500033 ? 91 8897263534
info_at_tbrc.info
8
Your Growth Insights Partner